Carbapenemase Gene Transmission in Enterobacter cloacae

Study Background and Research Question

Carbapenem-resistant Enterobacter cloacae (CREC) is an important healthcare-associated pathogen because resistance can combine limited treatment options with mobile genetic elements that move between bacterial lineages. The reference study, published in BMC Microbiology in 2025, addresses this problem in the context of post-pandemic hospital surveillance. The authors focused on whether carbapenemase-encoding genes (CEGs) were located on chromosomes, plasmids, or both; how strongly they were associated with multidrug resistance; and whether their genetic context supported intercellular transmission.

The investigation analyzed 54 CREC isolates collected from eight teaching hospitals in Guangdong Province, China, between December 2022 and June 2024. These details define the study’s epidemiological frame rather than a national prevalence estimate. The authors’ research question was therefore both molecular and operational: which carbapenemase genes are present, how are they physically maintained, and what evidence indicates that they can disseminate across clinical isolates? The full design and results are reported in the reference study.

Key Innovation from the Reference Study

The study’s main innovation is its integrated view of resistance transmission. Instead of treating PCR positivity as an endpoint, the authors combined plasmid elimination, phenotypic susceptibility testing, conjugation, mobile genetic element profiling, and ERIC-PCR strain typing. This approach distinguishes several related but nonidentical processes: the presence of a CEG, its physical localization, its ability to transfer, and the clonal relatedness of isolates carrying it.

This distinction is particularly important for bla_NDM-1. A resistance gene on a conjugative plasmid may spread horizontally between unrelated bacteria, whereas a chromosomal copy may be maintained primarily through clonal expansion or vertical inheritance. Detecting the same gene in both compartments suggests that resistance can persist through more than one route. The paper consequently contributes more than a gene-frequency survey; it provides a transmission-oriented framework for bacterial protein synthesis research and the study of antibiotic resistance mechanisms.

The work is also notable for examining multiple hospitals and departments rather than a single outbreak setting. Its strain-typing results help evaluate whether geographically distributed isolates represent one dominant clone or several backgrounds acquiring related resistance determinants. That combination of local surveillance and mechanistic testing makes the paper useful for infection-control interpretation.

Methods and Experimental Design Insights

The experimental workflow began with detection and localization of CEGs. The authors used a variable-temperature sodium dodecyl sulfate plasmid elimination method, followed by PCR, to infer whether target genes were plasmid-borne, chromosomal, or present in both locations. This is a practical strategy for a hospital isolate collection because it connects molecular detection to the physical replicon carrying the gene. However, it should be understood as a localization approach rather than a complete substitute for long-read whole-genome sequencing.

Phenotypic resistance was measured with broth microdilution. The study compared CEG-positive and CEG-negative groups against imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin. Broth microdilution is valuable here because it tests whether the genetic findings correspond to an expanded resistance phenotype, while also allowing an aminoglycoside antibiotic to be assessed alongside carbapenems, cephalosporins, and fluoroquinolones.

Plasmid conjugation experiments provided a functional test of transferability. PCR analysis of transconjugants was then used to determine which CEGs had moved successfully. This step is more informative than simply identifying plasmid location: plasmid association indicates potential mobility, whereas successful conjugation demonstrates that transfer occurred under the experimental conditions used.

Finally, six classes of mobile genetic elements were characterized, and ERIC-PCR followed by NTSYS software analysis grouped the isolates according to genomic fingerprint patterns. ERIC-PCR is suitable for screening relatedness in a collection, although it generally has lower resolution than core-genome multilocus sequence typing or whole-genome comparisons. The complementary methods therefore provide a layered design: PCR identifies genes, plasmid elimination estimates location, susceptibility testing measures phenotype, conjugation tests horizontal transfer, and fingerprinting examines strain distribution.

Protocol Parameters

• Isolate collection: The reference workflow used CREC isolates from eight teaching hospitals collected from December 2022 through June 2024. This is the study population, not a universal sampling requirement.
• Gene localization: Variable-temperature SDS plasmid elimination was followed by PCR to distinguish plasmid-associated and chromosomal CEG signals. Orthogonal genomic confirmation would strengthen future studies.
• Susceptibility testing: Broth microdilution compared CEG-positive and CEG-negative isolates across six clinically relevant antibiotics, including gentamicin. Interpretive breakpoints should follow the laboratory standard selected for a new experiment.
• Transfer assessment: Conjugation experiments combined with PCR of recipient or transconjugant colonies were used to test whether resistance genes could move between bacteria.
• Relatedness analysis: ERIC-PCR and NTSYS clustering were used as a screening-level approach to compare isolate fingerprints; higher-resolution sequencing is appropriate when investigating a suspected outbreak.

Why this cross-domain matters, maturity, and limitations

The paper connects clinical microbiology surveillance with laboratory assays that model resistance dissemination. That bridge is scientifically justified because the same isolate can be evaluated at the levels of genotype, phenotype, plasmid mobility, and clonal relatedness. It does not, however, convert the study into a Gram-negative bacterial infection model or establish how transfer occurs in a patient. The evidence is strongest for laboratory-measured association and transfer potential; its maturity for predicting bedside transmission remains limited by sampling, local epidemiology, and assay conditions.

Core Findings and Why They Matter

CEGs were detected in 46 of 54 isolates, corresponding to 85.19% of the collection. The bla_NDM-1 gene was the dominant pattern: 18 isolates carried it on both chromosomes and plasmids, while 25 carried it only on plasmids. Two isolates carried only plasmid-associated bla_IMP, and one carried plasmid-associated bla_NDM-1 together with bla_KPC-2. These distributions, reported in the primary article, emphasize that plasmid-associated NDM-1 was more than an incidental finding.

The CEG-positive group showed significantly higher resistance rates than the CEG-negative group for imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin, with reported statistical significance at P<0.05. The result supports a clinically important interpretation: carbapenemase carriage in this collection marked a broader multidrug-resistant phenotype rather than resistance to carbapenems alone. It also illustrates why gentamicin susceptibility should be interpreted as part of a complete antibiogram, not inferred from the presence or absence of one resistance gene.

Transfer experiments showed CEG movement in 44 of 46 CEG-positive isolates, a success rate of 95.65%. The transfer success was 42 of 44 for bla_NDM-1, 2 of 2 for bla_IMP, and 0 of 1 for bla_KPC-2. These findings distinguish gene-specific behavior and caution against assuming that every plasmid-associated carbapenemase has the same conjugative capacity.

ISEcp1 was the most prevalent mobile element, detected in 47 of 54 isolates, or 87.04%. Isolates carrying four mobile-element types simultaneously were the largest category, representing 22 of 54 strains, or 40.74%. The association of carbapenemase genes with several mobility-related elements provides a plausible genetic basis for dissemination, although the study does not prove that every element directly mobilized a specific gene.

ERIC-PCR divided the 54 isolates into 17 genotypes. Types E and G were each represented by 11 isolates, or 20.37%, and were recovered from different departments in five hospitals. Two type E isolates had a Dice coefficient of 100%, suggesting highly similar fingerprints. Together, these results support both horizontal gene transfer and distribution of related strains, but they do not by themselves establish a single interhospital outbreak.

The clinical distribution also has surveillance value. Men accounted for 35 isolates, elderly patients for 39, respiratory medicine for 11, and sputum specimens for 18, corresponding respectively to 64.81%, 72.22%, 20.37%, and 33.33% of the collection. These patterns identify groups and specimen types that may warrant focused monitoring, while not demonstrating that sex, age, department, or specimen type independently caused CEG acquisition.

Comparison with Existing Internal Articles

The internal article Carbapenemase Gene Dynamics in Enterobacter cloacae in China provides a concise epidemiological interpretation of the same Guangdong hospital study, emphasizing prevalence, mobility, and infection-control relevance. The primary paper is more useful for researchers who need the actual experimental architecture and gene-specific transfer results.

A second resource, Gentamycin Sulfate in CREC Resistance Research, frames how aminoglycoside exposure and susceptibility data might be incorporated into broader resistance workflows. Its scope is more application-oriented than the reference paper. The paper itself does not test a ribosome-directed intervention or establish that gentamicin changes carbapenemase mobility, so such workflows should be treated as follow-up research rather than as conclusions from this study.

Limitations and Transferability

The sample was limited to 54 isolates from eight teaching hospitals in one province and one collection period. Consequently, the reported proportions should not be generalized directly to all Chinese hospitals or to other regions. The study also used PCR, plasmid elimination, conjugation, mobile-element detection, and ERIC-PCR without providing the resolution of complete long-read genomic assemblies. Plasmid backbones, insertion sites, copy number, and full resistance islands therefore remain incompletely resolved.

Conjugation success demonstrates transfer under laboratory conditions, not transmission frequency in patients or hospital environments. Likewise, ERIC-PCR similarity can support an epidemiological hypothesis but cannot replace whole-genome comparison when distinguishing recent transmission from shared ancestry. Future work could strengthen transferability by combining longitudinal sampling, detailed plasmid sequencing, recipient-specific controls, and clinical metadata. These limitations do not undermine the paper’s central message; they define how far its conclusions can be extended.

Research Support Resources

For follow-up bacterial protein synthesis research, ribosome function analysis, or susceptibility-comparator experiments involving an aminoglycoside antibiotic, researchers can use Gentamycin Sulfate (SKU A2514) to support similar workflows. The product information describes it as a bacterial 30S ribosomal subunit inhibitor with reported purity of at least 98% and storage at −20°C; solutions should be prepared and used according to the experimental plan rather than stored long term. This reagent supports mechanistic or control assays, but it does not substitute for the plasmid, conjugation, and genomic analyses required to evaluate carbapenemase transmission.